Nasal Drug Delivery Technology Market

The Global Nasal Drug Delivery Technology Market is valued at USD 68.49 Billion in 2022 and is expected to reach USD 112.74 Billion by 2029 with a CAGR of 7.38% over the forecast period.

Global Nasal Drug Delivery Technology Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2023-2029-  Rising prevalence of asthma and growing availability of number of nasal drug delivery options are some of the major factors anticipated to drive the growth Global Nasal Drug Delivery Technology within the forecast period.

Scope–

Nasal drug delivery is type of route of administration of bioactive molecules through the nasal mucosa. The use of the nasal route for the delivery of gaining attention due to the high permeability, excellent penetration, low dose required, rapid absorption, low enzymatic environment of nasal cavity and avoidance of hepatic first pass metabolism are well suitable for systemic delivery of drug molecule via nose. The saturation of bioactive molecules through the nasal mucosa has been shown to achieve good bioavailability, and nasal sprays offer patients greater convenience. Nasal drug delivery is an ancient practice, but interest in it has recently grown due to its incredible benefits. Nasal drug delivery has various applications, such as being a suitable delivery method for drugs that are active at low doses, and it has been identified as having the potential to set noteworthy milestones in the pharmaceutical industry due to its skill to treat local infections and chronic allergies.

Overall, the Covid-19 pandemic has presented both challenges and opportunities for the global nasal drug delivery technology market. While the market has experienced disruptions, the increased demand for nasal delivery systems and the focus on developing Covid-19 treatments and vaccines using these systems is expected to drive continued growth in the coming years. 

The global nasal drug delivery technology market is segmented on the basis of system, dosage, end-users and region & country level. On the basis of type nasal Unidose devices, nasal bi dose devices, nasal multi dose devices. On the basis by dosage, the market is segmented into nasal spray, nasal drops and liquids, nasal gels, nasal powders and other dosage form. On the basis of end users, the market is segmented into  hospitals, home health care,  ambulatory surgery centers, specialty clinics, vaccination centers and others.

The regions covered in global nasal drug delivery technology market report are North America, Europe, Asia-Pacific, Latin America, and Rest of the World. Based on country level, the market of global nasal drug delivery technology market is subdivided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, India, Japan, Southeast Asia, Middle East Asia (UAE, Egypt, Saudi Arabia) GCC, Africa, etc.

Key Players-

Some of the key players for global nasal drug delivery technology market are -

• AptarGroup Inc.
• 3M Pharmaceuticals
• AstraZeneca plc
• Becton, Dickinson and Company (BD)
• GlaxoSmithKline plc
• Johnson & Johnson Services, Inc.
• Kurve Technology, Inc.
• MedImmune, LLC (AstraZeneca)
• Merck & Co., Inc.
• Novartis AG
• OptiNose AS
• Pfizer Inc.
• Teva Pharmaceutical Industries Ltd.
• Vectura Group plc
• Others

Segmentation-

By Device Type

• Nasal Unidose Devices
• Nasal Bi Dose Devices
• Nasal Multi Dose Devices

By Dosage

• Nasal Spray
• Nasal Drops and Liquids
• Nasal Gels
• Nasal Powders
• Other Dosage Form

By End User

• Hospitals
• Home Health Care
• Ambulatory Surgery Center
• Specialty Clinics
• Vaccination Centers
• Others

By Regional & Country Level:

• North America

  • U.S.
  • Canada

• Europe

  • U.K.
  • France
  • Germany
  • Italy

• Asia Pacific

  • China
  • Japan
  • India
  • Southeast Asia

• Latin America

  • Brazil
  • Mexico

• Middle East and Africa

  • GCC
  • Africa
  • Rest of Middle East and Africa

Rising Prevalence of Asthma and Growing Availability of Number of Nasal Drug Delivery Options are Some of the Major Factors Anticipated to Drive the Market Growth

One of the major factors driving the growth of the global drug delivery technology market is the soaring demand for nasal drug delivery products. Nasal drug delivery results in rapid drug absorption and onset of action, and drugs that are not absorbed orally can be delivered to the systemic circulation via nasal drug delivery. This method is also more convenient for the patients, especially those on long-term therapy, when compared with parenteral medication. Hence, nasal drug delivery is a promising alternative route of administration, administration  for  in  terms of  improved patient acceptability.

In addition, the rising prevalence of asthma is another factor driving the market growth. The rising number of asthma patients directly increases the market for nasal sprays and, in turn, fuels the nasal drug delivery market. According to the World Health Organization (WHO), asthma affected an estimated 262 million people in 2019 and killed 455,000 people.

Moreover, the growing availability of more nasal drug delivery options is also expanding the market's growth. The easy availability of various nasal delivery options and the development of newer products are expected to fuel market growth. For instance; in 2019, Lupin launched "Adhero," a first-of-its-kind connected smart device in India to support treatment of respiratory disease, and the U.S. Food and Drug Administration (FDA) approved BAQSIMI (glucagon) nasal powder of 3 mg to treat severe hypoglycemia in people with diabetes ages four and above in July 2019.

However, limitations associated with nasal drug delivery, such as the risk of local side effects, may hamper the market growth. Despite this, growing advancements in the nasal drug delivery technologies may offers more opportunities for the further growth of the global nasal drug delivery technology market. 

North America is Expected to Dominate the Global Nasal Drug Delivery Technology Market

North America is expected to dominate the global nasal drug delivery technology market owing to the rising number of asthma patients, increasing number of product launches and growing adoption of early treatment procedures in this region. For instance; 8.3% of Americans have asthma as per the American College of Allergy. Thus, increasing number of individuals with asthma is augmenting the market growth of global nasal drug delivery technology market. In addition, rising product launches also acerating the market growth. For instance; launch of first-to-market generic version of Narcan (naloxone hydrochloride nasal spray), in the U.S announced by Teva.

Asia Pacific is fastest growing region in the global nasal drug delivery technology market due to increase awareness, rising disposable incomes and research and developments in nasal drug delivery technologies. For instance; in 2020 Aptar Pharma and Lupin launched  India’s first connected device for metered-dose inhalers (MDI) called ADHERO.

News-

Aptar Pharma Launched Metal-Free Nasal Spray Pump

On February 13^th, 2023; APF Futurity, its first metal-free, multidose nasal spray pump, was developed to deliver nasal saline and other comparable over-the-counter (OTC) formulations launched by Aptar Pharma. Specifically designed for recyclability, APF Futurity is Aptar Pharma’s first highly recyclable nasal spray pump, having achieved a Class AA certification from Cyclos-HTP for recycling streams in Europe.

Report Analysis	Details
Historical data	2016 - 2021
Forecast Period	2022 - 2029
Market Size in 2022:	USD 68.49 Billion
Base year considered	2021
Forecast Period CAGR %:	7.38%
Market Size Expected in 2029:	USD 112.74 Billion
Tables, Charts & Figures:	175
Pages	300
Key Players/Companies	AptarGroup Inc., 3M Pharmaceuticals, AstraZeneca plc, Becton, Dickinson and Company (BD), GlaxoSmithKline plc, Johnson & Johnson Services, Inc., Kurve Technology, Inc., MedImmune, LLC (AstraZeneca), Merck & Co., Inc., Novartis AG, OptiNose AS, Pfizer Inc., Teva Pharmaceutical Industries Ltd., Vectura Group plc, Others.
Segments Covered	By System, By Dosage & By End-User
Regional Analysis